We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.
Features Partner Sites Information LinkXpress
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
GLOBETECH PUBLISHING LLC

Pathology

Image: A malignant melanoma of the skin (Photo courtesy of Juan Gaertner).

Circulating Tumor DNA Detects Early Melanoma Growth

According to the National Cancer Institute, there were 91,270 new cases of melanoma in 2018, making up more than 5% of all new cancer cases. There were 9,320 estimated deaths in 2018, and 91.8% of patients survive five years or longer. More...
11 Dec 2018

TURN SMALL PLACES INTO SMART SPACES
The new CELL-DYN Emerald 22 AL is a full performance, automated optical 5-part differential analyzer that delivers smarter results for small to mid-size clinical laboratories.
[Abbott Diagnostics]
Image: A diagram of the basis of the IvyGene Methylation-Based Liquid Biopsy Test to detect cancer (Photo courtesy of Dr. Kevin Conners).

Methylation-Based Liquid Biopsy Test Detects Liver Cancer

Hepatocellular carcinoma (HCC) represents about 75% of liver cancers in the USA and already has well-established screening criteria focused largely on individuals with cirrhosis, who are screened every six months using ultrasound with or without blood testing for alpha- fetoprotein, according to guidelines. More...
06 Dec 2018
Image: The CellSearch Platform for identification, isolation, and enumeration of circulating tumor cells (Photo courtesy of Menarini Silicon Biosystems).

Liquid Biopsy Detects Cancer across Multiple Biomarkers

Although biomarker-directed therapy is in its infancy in prostate cancer compared to some other tumor types, there is a great need for predictive biomarker testing, and great interest in noninvasive methods. However, comprehensive analysis of patients' cell-free DNA has been limited to date. More...
06 Dec 2018
Image: The NextSeq 550 System delivers the power of high-throughput sequencing with the speed, simplicity, and affordability of a benchtop next-generation sequencing (NGS) system (Photo courtesy of Illumina).

Genes Identified That Predispose People to Chronic Kidney Disease

Chronic kidney disease (CKD) affects 10% to 15% of the population worldwide and is now recognized as the most rapidly increasing contributor to global burden of disease. The costs related to CKD and end-stage renal disease (the terminal manifestation of CKD) are an enormous burden for all healthcare systems around the world. More...
05 Dec 2018

New DxH 520:* maximum productivity
Boost productivity and deliver accurate results with dynamic gating—a proprietary solution that reduces unnecessary flagging while maintaining clinical sensitivity. Watch video. *Pending 510(k) clearance.
[BECKMAN COULTER, INC.]
Image: The IMMULITE 1000 system is a small bench top immunoassay analyzer (Photo courtesy of Siemens Healthcare Diagnostics).

Levels of IgA Nephropathy Associated with Disease Severity

IgA nephropathy (IgAN) is the most common cause of primary glomerulonephritis. IgAN is associated with a poor prognosis, about 20% to 40% of patients with IgAN progress slowly to end-stage renal failure 20 to 25 years after diagnosis. More...
03 Dec 2018
Image: The ability to detect cell-free circulating tumor DNA in blood provides the opportunity to develop non-invasive tests to measure tumor burden and detect molecular signatures in tumors that are associated with resistance to therapy (Photo courtesy of Huntsman Cancer Institute).

Sensitive Tumor Detection Uses Cell-Free DNA Methylomes

A combination of "liquid biopsy," epigenetic alterations and machine learning has been used to develop a blood test to detect and classify cancer at its earliest stages. The method holds promise of being able to find cancer earlier when it is more easily treated and long before symptoms ever appear. More...
27 Nov 2018
Image: The Quant-iT high sensitivity PicoGreen double-stranded DNA Assay Kit (Photo courtesy of Invitrogen).

Biomarker Found for Prostate Cancer Treatment Response

Prostate cancer is one of the most common cancers in males and has one of the highest five-year survival rate when diagnosed in the localized stage. When diagnosed in the advanced stage or when a localized tumor relapses after the initial local treatment, the usual procedure is to fight it using male hormone (androgen) deprivation therapy. More...
27 Nov 2018

In Other News



The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chemistry
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Lab Tech.
Industry News
Events

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

TradeMed.comBiotechDaily.comHospiMedica.com Globetech.net
Copyright © 2000-2018 Globetech Media. All rights reserved.
MOBILE | FULL SITE